| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Maryam Haghshenas, Mohammad Taghi Akbari, Shohreh Zare Karizi, Faravareh Khordadpoor Deilamani, Shahriar Nafissi, Zivar Saleh. Evaluation of point mutations in dystrophin gene in Iranian Duchenne and Becker muscular dystrophy patients: introducing three novel variants. Journal of genetics. vol 95. issue 2. 2017-03-28. PMID:27350676. |
duchenne and becker muscular dystrophies (dmd and bmd) are x-linked neuromuscular diseases characterized by progressive muscular weakness and degeneration of skeletal muscles. |
2017-03-28 |
2023-08-13 |
Not clear |
| Stijn Oonk, Pietro Spitali, Monika Hiller, Linda Switzar, Hans Dalebout, Mattia Calissano, Hanns Lochmüller, Annemieke Aartsma-Rus, Peter A C 't Hoen, Yuri E M van der Burg. Comparative mass spectrometric and immunoassay-based proteome analysis in serum of Duchenne muscular dystrophy patients. Proteomics. Clinical applications. vol 10. issue 3. 2017-01-09. PMID:26680509. |
duchenne muscular dystrophy (dmd) is a severe and fatal neuromuscular disease. |
2017-01-09 |
2023-08-13 |
Not clear |
| Cara A Timpani, Alan Hayes, Emma Rybalk. Revisiting the dystrophin-ATP connection: How half a century of research still implicates mitochondrial dysfunction in Duchenne Muscular Dystrophy aetiology. Medical hypotheses. vol 85. issue 6. 2016-10-05. PMID:26365249. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease that is characterised by dystrophin-deficiency and chronic ca(2+)-induced skeletal muscle wasting, which currently has no cure. |
2016-10-05 |
2023-08-13 |
Not clear |
| J Fagoaga, M Girabent-Farres, C Bagur-Calafat, B F Steffense. [Evolution of functional capacity, assessed with the Egen Klassifikation scale, in the Spanish population with spinal muscular atrophy or Duchenne muscular dystrophy. A three year longitudinal study]. Revista de neurologia. vol 61. issue 8. 2016-08-31. PMID:26461127. |
spinal muscular atrophy (sma) and duchenne muscular dystrophy (dmd) are two neuromuscular diseases which evolve with a progressive loss of muscle strength and, therefore, the loss of functional capacity. |
2016-08-31 |
2023-08-13 |
Not clear |
| Pam M Van Ry, Ryan D Wuebbles, Megan Key, Dean J Burki. Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy. Molecular therapy : the journal of the American Society of Gene Therapy. vol 23. issue 8. 2016-05-10. PMID:26050991. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease caused by mutations in the dystrophin gene, leading to the loss of a critical component of the sarcolemmal dystrophin glycoprotein complex. |
2016-05-10 |
2023-08-13 |
mouse |
| Claire Latroche, Béatrice Matot, Aurea Martins-Bach, David Briand, Bénédicte Chazaud, Claire Wary, Pierre G Carlier, Fabrice Chrétien, Grégory Jouvio. Structural and Functional Alterations of Skeletal Muscle Microvasculature in Dystrophin-Deficient mdx Mice. The American journal of pathology. vol 185. issue 9. 2016-05-10. PMID:26193666. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease, caused by an absence of dystrophin, inevitably leading to death. |
2016-05-10 |
2023-08-13 |
mouse |
| Emma Tuckett, Troy Gosetti, Alan Hayes, Emma Rybalka, Elizabeth Verghes. Increased calcium in neurons in the cerebral cortex and cerebellum is not associated with cell loss in the mdx mouse model of Duchenne muscular dystrophy. Neuroreport. vol 26. issue 13. 2016-05-02. PMID:26177336. |
duchenne muscular dystrophy (dmd) is a fatal neuromuscular disease resulting from mutation of the x-linked dystrophin gene. |
2016-05-02 |
2023-08-13 |
mouse |
| Tatiana M Pizzato, Cyntia R J A Baptista, Mariana A Souza, Michelle M B Benedicto, Edson Z Martinez, Ana C Mattiello-Sverzu. Longitudinal assessment of grip strength using bulb dynamometer in Duchenne Muscular Dystrophy. Brazilian journal of physical therapy. vol 18. issue 3. 2016-03-31. PMID:25003277. |
however, this relationship is controversial in neuromuscular diseases and studies with the bulb dynamometer comparing healthy children and children with duchenne muscular dystrophy (dmd) are limited. |
2016-03-31 |
2023-08-13 |
Not clear |
| Rachid Benchaouir, Valerie Robin, Aurelie Goyenvall. Gene and splicing therapies for neuromuscular diseases. Frontiers in bioscience (Landmark edition). vol 20. 2016-03-24. PMID:25961553. |
in this review, we summarize the recent progress of therapeutic approaches to neuromuscular diseases, with an emphasis on gene therapy and splicing modulation for dmd and sma, focusing on the advantages offered by these technologies but also their challenges. |
2016-03-24 |
2023-08-13 |
Not clear |
| Florence Robriquet, Aurélie Lardenois, Candice Babarit, Thibaut Larcher, Laurence Dubreil, Isabelle Leroux, Céline Zuber, Mireille Ledevin, Jack-Yves Deschamps, Yves Fromes, Yan Cherel, Laetitia Guevel, Karl Rouge. Differential Gene Expression Profiling of Dystrophic Dog Muscle after MuStem Cell Transplantation. PloS one. vol 10. issue 5. 2016-02-01. PMID:25955839. |
several adult stem cell populations exhibit myogenic regenerative potential, thus representing attractive candidates for therapeutic approaches of neuromuscular diseases such as duchenne muscular dystrophy (dmd). |
2016-02-01 |
2023-08-13 |
dog |
| Nicholas P Whitehead, Min Jeong Kim, Kenneth L Bible, Marvin E Adams, Stanley C Froehne. A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophy. Proceedings of the National Academy of Sciences of the United States of America. vol 112. issue 41. 2016-01-25. PMID:26417069. |
together, our findings highlight that simvastatin substantially improves the overall health and function of dystrophic skeletal muscles and may provide an unexpected, novel therapy for dmd and related neuromuscular diseases. |
2016-01-25 |
2023-08-13 |
mouse |
| Elżbieta Krasowska, Krzysztof Zabłocki, Dariusz C Górecki, Jerome D Swinn. Aberrant location of inhibitory synaptic marker proteins in the hippocampus of dystrophin-deficient mice: implications for cognitive impairment in duchenne muscular dystrophy. PloS one. vol 9. issue 9. 2015-12-30. PMID:25260053. |
duchenne muscular dystrophy (dmd) is a neuromuscular disease that arises from mutations in the dystrophin-encoding gene. |
2015-12-30 |
2023-08-13 |
mouse |
| Luz Berenice López-Hernández, Benjamín Gómez-Díaz, Alexandra Berenice Luna-Angulo, Mónica Anaya-Segura, David John Bunyan, Carolina Zúñiga-Guzman, Rosa Elena Escobar-Cedillo, Bladimir Roque-Ramírez, Luis Angel Ruano-Calderón, Héctor Rangel-Villalobos, Julia Angélica López-Hernández, Francisco Javier Estrada-Mena, Silvia García, Ramón Mauricio Coral-Vázque. Comparison of mutation profiles in the Duchenne muscular dystrophy gene among populations: implications for potential molecular therapies. International journal of molecular sciences. vol 16. issue 3. 2015-11-25. PMID:25761239. |
novel therapeutic approaches are emerging to restore dystrophin function in duchenne muscular dystrophy (dmd), a severe neuromuscular disease characterized by progressive muscle wasting and weakness. |
2015-11-25 |
2023-08-13 |
Not clear |
| Stephen J P Pratt, Ana P Valencia, Gloribel K Le, Sameer B Shah, Richard M Loverin. Pre- and postsynaptic changes in the neuromuscular junction in dystrophic mice. Frontiers in physiology. vol 6. 2015-10-07. PMID:26441672. |
duchenne muscular dystrophy (dmd) is a devastating neuromuscular disease in which weakness, increased susceptibility to muscle injury, and inadequate repair appear to underlie the pathology. |
2015-10-07 |
2023-08-13 |
mouse |
| Yinghui Ye, Ping Yu, Jing Yong, Ting Zhang, Xiaoming Wei, Ming Qi, Fan Ji. Preimplantational genetic diagnosis and mutation detection in a family with duplication mutation of DMD gene. Gynecologic and obstetric investigation. vol 78. issue 4. 2015-08-05. PMID:25196347. |
duchenne muscular dystrophy (dmd) is an x-linked recessive neuromuscular disease caused by mutation in the dmd gene. |
2015-08-05 |
2023-08-13 |
Not clear |
| Laurence Jeanson-Leh, Julie Lameth, Soraya Krimi, Julien Buisset, Fatima Amor, Caroline Le Guiner, Inès Barthélémy, Laurent Servais, Stéphane Blot, Thomas Voit, David Israel. Serum profiling identifies novel muscle miRNA and cardiomyopathy-related miRNA biomarkers in Golden Retriever muscular dystrophy dogs and Duchenne muscular dystrophy patients. The American journal of pathology. vol 184. issue 11. 2015-07-21. PMID:25194663. |
duchenne muscular dystrophy (dmd) is a fatal, x-linked neuromuscular disease that affects 1 boy in 3500 to 5000 boys. |
2015-07-21 |
2023-08-13 |
dog |
| Sara Vianello, Sophie Bouyon, Evelyne Benoit, Catherine Sebrié, Delphine Boerio, Marc Herbin, Morgane Roulot, Yves Fromes, Sabine de la Port. Arginine butyrate per os protects mdx mice against cardiomyopathy, kyphosis and changes in axonal excitability. Neurobiology of disease. vol 71. 2015-06-02. PMID:25167832. |
duchenne muscular dystrophy (dmd) is a progressive neuromuscular disease caused by lack of dystrophin, a sub-sarcolemmal protein, which leads to dramatic muscle deterioration. |
2015-06-02 |
2023-08-13 |
mouse |
| Stephen J P Pratt, Sameer B Shah, Christopher W Ward, Jaclyn P Kerr, Joseph P Stains, Richard M Loverin. Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury. Cellular and molecular life sciences : CMLS. vol 72. issue 1. 2015-03-03. PMID:24947322. |
duchenne muscular dystrophy (dmd) is a devastating neuromuscular disease in which weakness, increased susceptibility to muscle injury, and inadequate repair underlie the pathology. |
2015-03-03 |
2023-08-13 |
mouse |
| Richard M Lovering, Susan V Brook. Eccentric exercise in aging and diseased skeletal muscle: good or bad? Journal of applied physiology (Bethesda, Md. : 1985). vol 116. issue 11. 2015-01-22. PMID:23471953. |
evidence is accumulating regarding the benefits of exercise in people who are more susceptible to injury, such as the elderly, or those with a neuromuscular disease, for example duchenne muscular dystrophy (dmd). |
2015-01-22 |
2023-08-12 |
Not clear |
| Cecilia Riquelme, María José Acuña, Javiera Torrejón, Daniela Rebolledo, Daniel Cabrera, Robson A Santos, Enrique Branda. ACE2 is augmented in dystrophic skeletal muscle and plays a role in decreasing associated fibrosis. PloS one. vol 9. issue 4. 2015-01-20. PMID:24695436. |
duchenne muscular dystrophy (dmd) is the most common inherited neuromuscular disease and is characterized by absence of the cytoskeletal protein dystrophin, muscle wasting, and fibrosis. |
2015-01-20 |
2023-08-13 |
mouse |